Beijing Konruns Pharmaceutical Co., Ltd.SSE: 603590

Announcement on Progress in Repurchasing Shares

Jun 2, 2026 · Issued by Beijing Konruns Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 2, 2026

On 6ix: 6ix.com/news/announcement-on-progress-in-repurchasing-shares-94

Announcement on Progress in Repurchasing Shares

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Beijing Konruns Pharmaceutical Co., Ltd. on 6ix

Earlier from Beijing Konruns Pharmaceutical

Announcement on presentation of KC1036 for the treatment of advanced thymic tumors in the form of a poster at the 2026 ASCO Annual MeetingMay 29
Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash ManagementMay 16
Announcement on Resolutions of the 2025 Annual General MeetingMay 15
Announcement on the Acceptance of the Marketing Authorization Application for Jincaopian TabletsApr 25
Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026Apr 24

Later from Beijing Konruns Pharmaceutical

Announcement on Progress in Repurchasing 1% Shares through Call Auction and Repurchasing SharesJun 12
Announcement on Adjusting Total Cash Dividends for 2025 Annual Profit DistributionJun 16
Announcement on Achieving Conditions for Lifting Sales Restrictions in 3rd Lifting Period of Initially Granted Part and 2nd Lifting Period of Reserved Granted Part under the 2023 Restricted Stock Incentive PlanJun 24
Announcement on Implementation of Dividend Distribution for 2025Jul 1
Announcement on the Change in the Company's Registered CapitalJul 4

All Beijing Konruns Pharmaceutical news releases

Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.

Follow Beijing Konruns Pharmaceutical